Cognitive therapy vs medications in the treatment of moderate to severe depression

被引:659
作者
DeRubeis, RJ [1 ]
Hollon, SD
Amsterdam, JD
Shelton, RC
Young, PR
Salomon, RM
O'Reardon, JP
Lovett, ML
Gladis, MM
Brown, LL
Gallop, R
机构
[1] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
[3] Vanderbilt Univ, Dept Psychol, Nashville, TN USA
[4] Vanderbilt Univ, Dept Psychiat, Nashville, TN USA
[5] W Chester Univ, Dept Math & Appl Stat, W Chester, PA USA
关键词
D O I
10.1001/archpsyc.62.4.409
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: There is substantial evidence that antidepressant medications treat moderate to severe depression effectively, but there is less data on cognitive therapy's effects in this population. Objective: To compare the efficacy in moderate to severe depression of antidepressant medications with cognitive therapy in a placebo-controlled trial. Design: Random assignment to one of the following: 16 weeks of medications (n = 120), 16 weeks of cognitive therapy (n = 60), or 8 weeks of pill placebo (n = 60). Setting: Research clinics at the University of Pennsylvania, Philadelphia, and Vanderbilt University, Nashville, Tenn. Patients: Two hundred forty outpatients, aged 18 to 70 years, with moderate to severe major depressive disorder. Interventions: Some study subjects received paroxetine, up to 50 mg daily, augmented by lithium carbonate or desipramine hydrochloride if necessary; others received individual cognitive therapy. Main Outcome Measure: The Hamilton Depression Rating Scale provided continuous severity scores and allowed for designations of response and remission. Results: At 8 weeks, response rates in medications (50%) and cognitive therapy (43%) groups were both superior to the placebo (25%) group. Analyses based on continuous scores at 8 weeks indicated an advantage for each of the active treatments over placebo, each with a medium effect size. The advantage was significant for medication relative to placebo, and at the level of a nonsignificant trend for cognitive therapy relative to placebo. At 16 weeks, response rates were 58% in each of the active conditions; remission rates were 46% for medication, 40% for cognitive therapy. Follow-up tests of a site X treatment interaction indicated a significant difference only at Vanderbilt University, where medications were superior to cognitive therapy. Site differences in patient characteristics and in the relative experience levels of the cognitive therapists each appear to have contributed to this interaction. Conclusion: Cognitive therapy can be as effective as medications for the initial treatment of moderate to severe major depression, but this degree of effectiveness may depend on a high level of therapist experience or expertise.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 34 条
[1]  
American Psychiatric Association, 2013, Diagnostic and Statistical Manual of Mental Disorders, VFifth
[2]   Sustained efficacy of gepirone-IR in major depressive disorder: a double-blind placebo substitution trial [J].
Amsterdam, JD ;
Brunswick, DJ ;
Gibertini, M .
JOURNAL OF PSYCHIATRIC RESEARCH, 2004, 38 (03) :259-265
[3]  
[Anonymous], 2000, Am J Psychiatry, V157, P1
[4]  
Beck A.T., 1990, COGNITIVE THERAPY PE
[5]  
Beck AT., 1979, Cognitive Therapy of Depression
[6]  
Beck J.S., 2011, Cognitive Behavior Therapy: Basics and Beyond
[7]  
Bryk A, 1996, HIERARCHICAL LINEAR
[8]  
Cohen J., 1988, STAT POWER ANAL BEHA
[9]  
DeRubeis RJ, 1999, AM J PSYCHIAT, V156, P1007
[10]  
ELKIN I, 1989, ARCH GEN PSYCHIAT, V46, P971